Binding Site Human IgM Kit (for SPAPLUS), REF: NK012.S The device consists of reaction buffer, sheep anti-IgM antiserum, six calibrators and two controls. The calibrators and controls are based on stabilized human serum. All components contain sodium azide as a preservative and are provided in ready-to-use liquid format.
Published December 19, 2018 · Recall initiated: November 6, 2018
Summary
FDA records medical device Class II recall Z-0604-2019, published December 19, 2018 and initiated November 6, 2018. Recalling firm: The Binding Site Group, Ltd.; Status: Terminated; Reported quantity: 60; Lot: Lot 413849. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Firm is offering advice to customers experiencing challenges when validating the calibration curve of the IgM kits. This is indicated by kit control values reporting outside the specified ranges.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- The Binding Site Group, Ltd.
- Distributor
- U.S Distribution to states of: CA, IL, PA, FL, NE, WA, IN, NY, SD and VA,
- Lot
- Lot 413849
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United Kingdom
Related recalls
- FDABrand Name: EXENT Analyser Product Name: EXENT Analyser Model/Catalog Number: IE800.A Software Version: 1.0.20June 17, 2026
- FDAThe Optilite Clinical Chemistry Analyzer. IVD. Model Number: IE700. UDI-05051700017176 - Product Usage: TheMay 27, 2020
- FDAOPTILITE IgM Kit, REF: NK012.OPT.A, IVD, UDI: 05051700017565February 26, 2020
- FDAEstradiol Tablets, USP, 2 mg, 100-count bottle, Rx Only, Distributed by: Epic Pharma, LLC Laurelton, NY 11413,December 26, 2018
- FDAHemoglobin A1c Control, Part no. 220232 for use as quality control material to monitor the precision ofDecember 19, 2018
- FDABinding Site Optilite Beta-2-Microglobulin Urine Kit, Ref LK043.L.OPT.A, IVD. The firm name on the label isApril 11, 2018
Questions about this recall
Was Binding Site Human IgM Kit (for SPAPLUS), REF: NK012.S The device consists of reaction buffer, sheep anti-IgM antiserum, six calibrators and two controls. The calibrators and controls are based on stabilized human serum. All components contain sodium azide as a preservative and are provided in ready-to-use liquid format. recalled?
Yes. FDA published recall Z-0604-2019 on December 19, 2018. Reported hazard: Firm is offering advice to customers experiencing challenges when validating the calibration curve of the IgM kits. This is indicated by kit control values reporting outside the specified ranges.
What should I do if I have this product?
Voluntary: Firm initiated · Letter